Logo for InnoCan Pharma Corporation
INNO

InnoCan Pharma Corporation

Status
Active
Issued & Outstanding248,490,093
Reserved for Issuance14,344,806
Currency
CSE Index

About

InnoCan Pharma Corporation

Listing date
September 24, 2019

The Corporation's business can be described as three distinct operating segments relating to the incorporation in products of CBD in their formulation: (i) research, development, marketing, distribution and sales of InnoCan-branded OTC pharmaceutical products; (ii) research and development of non-pharmaceutical products for third parties in exchange for fees and/or royalties; and (iii) research and development of hydrogels containing liposomes intended for licensing or sale to third party pharmaceutical corporations for manufacturing, distribution and sales.